BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 30567732)

  • 21. Expression of PD-1, PD-L1, and PD-L2 in posttransplant lymphoproliferative disorder after solid organ transplantation.
    Kinch A; Sundström C; Baecklund E; Backlin C; Molin D; Enblad G
    Leuk Lymphoma; 2019 Feb; 60(2):376-384. PubMed ID: 30033844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells.
    Basso K; Saito M; Sumazin P; Margolin AA; Wang K; Lim WK; Kitagawa Y; Schneider C; Alvarez MJ; Califano A; Dalla-Favera R
    Blood; 2010 Feb; 115(5):975-84. PubMed ID: 19965633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality.
    Saha A; Aoyama K; Taylor PA; Koehn BH; Veenstra RG; Panoskaltsis-Mortari A; Munn DH; Murphy WJ; Azuma M; Yagita H; Fife BT; Sayegh MH; Najafian N; Socie G; Ahmed R; Freeman GJ; Sharpe AH; Blazar BR
    Blood; 2013 Oct; 122(17):3062-73. PubMed ID: 24030385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurons upregulate PD-L1 via IFN/STAT1/IRF1 to alleviate damage by CD8
    Wang Y; Shen Y; Liang J; Wang S; Huang Y; Zhu Q; Zhang X; Yu K; Tong G; Yang C; Li Y; Wang J; Zhao Y
    J Neuroinflammation; 2024 May; 21(1):119. PubMed ID: 38715061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis.
    Basso K; Dalla-Favera R
    Adv Immunol; 2010; 105():193-210. PubMed ID: 20510734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of programmed death 1 ligands by murine T cells and APC.
    Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
    J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone Arginine Methylation by PRMT7 Controls Germinal Center Formation via Regulating Bcl6 Transcription.
    Ying Z; Mei M; Zhang P; Liu C; He H; Gao F; Bao S
    J Immunol; 2015 Aug; 195(4):1538-47. PubMed ID: 26179907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PD-L1 upregulation by IFN-α/γ-mediated Stat1 suppresses anti-HBV T cell response.
    Liu L; Hou J; Xu Y; Qin L; Liu W; Zhang H; Li Y; Chen M; Deng M; Zhao B; Hu J; Zheng H; Li C; Meng S
    PLoS One; 2020; 15(7):e0228302. PubMed ID: 32628668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells.
    Good-Jacobson KL; Szumilas CG; Chen L; Sharpe AH; Tomayko MM; Shlomchik MJ
    Nat Immunol; 2010 Jun; 11(6):535-42. PubMed ID: 20453843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bcl6 protein expression shapes pre-germinal center B cell dynamics and follicular helper T cell heterogeneity.
    Kitano M; Moriyama S; Ando Y; Hikida M; Mori Y; Kurosaki T; Okada T
    Immunity; 2011 Jun; 34(6):961-72. PubMed ID: 21636294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphism of the programmed death-ligand 1 gene is associated with its protein expression and prognosis in gastric cancer.
    Wu Y; Zhao T; Jia Z; Cao D; Cao X; Pan Y; Zhao D; Zhang B; Jiang J
    J Gastroenterol Hepatol; 2019 Jul; 34(7):1201-1207. PubMed ID: 30353572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
    Phan RT; Dalla-Favera R
    Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Tumor-Specific Super-Enhancer Drives Immune Evasion by Guiding Synchronous Expression of PD-L1 and PD-L2.
    Xu Y; Wu Y; Zhang S; Ma P; Jin X; Wang Z; Yao M; Zhang E; Tao B; Qin Y; Chen H; Liu A; Chen M; Xiao M; Lu C; Mao R; Fan Y
    Cell Rep; 2019 Dec; 29(11):3435-3447.e4. PubMed ID: 31825827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Profiles of PD-1, PD-L1, PD-L2 in Gastric Cancer and Their Relation with Mutation, Immune Infiltration, and Survival.
    Liu J; Li H; Sun L; Yuan Y; Xing C
    Biomed Res Int; 2020; 2020():2496582. PubMed ID: 32596285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide Analysis Identifies Bcl6-Controlled Regulatory Networks during T Follicular Helper Cell Differentiation.
    Liu X; Lu H; Chen T; Nallaparaju KC; Yan X; Tanaka S; Ichiyama K; Zhang X; Zhang L; Wen X; Tian Q; Bian XW; Jin W; Wei L; Dong C
    Cell Rep; 2016 Feb; 14(7):1735-1747. PubMed ID: 26876184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell Immunity.
    Karunarathne DS; Horne-Debets JM; Huang JX; Faleiro R; Leow CY; Amante F; Watkins TS; Miles JJ; Dwyer PJ; Stacey KJ; Yarski M; Poh CM; Lee JS; Cooper MA; Rénia L; Richard D; McCarthy JS; Sharpe AH; Wykes MN
    Immunity; 2016 Aug; 45(2):333-45. PubMed ID: 27533014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis.
    Jardin F; Ruminy P; Bastard C; Tilly H
    Pathol Biol (Paris); 2007 Feb; 55(1):73-83. PubMed ID: 16815642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Verteporfin Inhibits PD-L1 through Autophagy and the STAT1-IRF1-TRIM28 Signaling Axis, Exerting Antitumor Efficacy.
    Liang J; Wang L; Wang C; Shen J; Su B; Marisetty AL; Fang D; Kassab C; Jeong KJ; Zhao W; Lu Y; Jain AK; Zhou Z; Liang H; Sun SC; Lu C; Xu ZX; Yu Q; Shao S; Chen X; Gao M; Claret FX; Ding Z; Chen J; Chen P; Barton MC; Peng G; Mills GB; Heimberger AB
    Cancer Immunol Res; 2020 Jul; 8(7):952-965. PubMed ID: 32265228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis.
    Zhu B; Guleria I; Khosroshahi A; Chitnis T; Imitola J; Azuma M; Yagita H; Sayegh MH; Khoury SJ
    J Immunol; 2006 Mar; 176(6):3480-9. PubMed ID: 16517716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. p110δ phosphoinositide 3-kinase represses IgE switch by potentiating BCL6 expression.
    Zhang TT; Makondo KJ; Marshall AJ
    J Immunol; 2012 Apr; 188(8):3700-8. PubMed ID: 22422878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.